Home Science An experimental lung-cancer drug could replace Keytruda...
Science

An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.

An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
Key Points

The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug

The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug
Keytruda (ORG)
Originally published by MarketWatch Read original →